These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31942057)

  • 1. The kill-switch for CRISPR that could make gene-editing safer.
    Dolgin E
    Nature; 2020 Jan; 577(7790):308-310. PubMed ID: 31942057
    [No Abstract]   [Full Text] [Related]  

  • 2. US defence agencies grapple with gene drives.
    Callaway E
    Nature; 2017 Jul; 547(7664):388-389. PubMed ID: 28748948
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversial CRISPR 'gene drives' tested in mammals for the first time.
    Callaway E
    Nature; 2018 Jul; 559(7713):164. PubMed ID: 29991786
    [No Abstract]   [Full Text] [Related]  

  • 4. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
    Giersch RM; Finnigan GC
    Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
    Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
    Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caution urged over editing DNA in wildlife (intentionally or not).
    Ledford H
    Nature; 2015 Aug; 524(7563):16. PubMed ID: 26245558
    [No Abstract]   [Full Text] [Related]  

  • 9. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Accelerated Gene Drives Pump the Brakes.
    LeMieux J
    CRISPR J; 2019 Aug; 2():196-198. PubMed ID: 31436503
    [No Abstract]   [Full Text] [Related]  

  • 11. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angels and Devils: Dilemmas in Dual-Use Biotechnology.
    Getz LJ; Dellaire G
    Trends Biotechnol; 2018 Dec; 36(12):1202-1205. PubMed ID: 30104010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guest editorial: CRISPRcas9: CRISPR-Cas systems: at the cutting edge of microbiology.
    Barrangou R; Bikard D
    Curr Opin Microbiol; 2017 Jun; 37():vii-viii. PubMed ID: 29096913
    [No Abstract]   [Full Text] [Related]  

  • 15. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CRISPR Path to Cutting-Edge Materials.
    Chen M; Luo D
    N Engl J Med; 2020 Jan; 382(1):85-88. PubMed ID: 31893521
    [No Abstract]   [Full Text] [Related]  

  • 17. Machine-learning approach expands the repertoire of anti-CRISPR protein families.
    Gussow AB; Park AE; Borges AL; Shmakov SA; Makarova KS; Wolf YI; Bondy-Denomy J; Koonin EV
    Nat Commun; 2020 Jul; 11(1):3784. PubMed ID: 32728052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guest Editorial Prospects in Biotechnology.
    Kas J; Chisti Y
    Biotechnol Adv; 2018; 36(3):555-556. PubMed ID: 29753362
    [No Abstract]   [Full Text] [Related]  

  • 19. A 'gene drive' makes its debut in mammals.
    Cohen J
    Science; 2018 Jul; 361(6398):118. PubMed ID: 30002234
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.